(Q41729533)

8 October 2017

title

The effects of propranolol on cognitive function and quality of life: a randomized trial among patients with diastolic hypertension (English)

1 reference

8 October 2017

1 reference

1 reference

7

Coates TJ

1 reference

8 October 2017

Pérez-Stable EJ

1

1 reference

8 October 2017

Halliday R

2

1 reference

8 October 2017

Gardiner PS

3

1 reference

8 October 2017

Baron RB

4

1 reference

8 October 2017

Hauck WW

5

1 reference

8 October 2017

Acree M

6

1 reference

8 October 2017

language of work or name

English

0 references

publication date

1 April 2000

1 reference

American Journal of Medicine

8 October 2017

published in

1 reference

8 October 2017

volume

108

1 reference

8 October 2017

issue

5

1 reference

8 October 2017

page(s)

359-365

1 reference

MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party

8 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900304-1

Effects of beta-blockers and calcium channel blockers in acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900304-1

Treatment for acute myocardial infarction. Overview of randomized clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900304-1

Trends in antihypertensive drug use in the United States: do the JNC V recommendations affect prescribing? Fifth Joint National Commission on the Detection, Evaluation, and Treatment of High Blood Pressure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900304-1

Quality of life and cost-effectiveness in the treatment of hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900304-1

Cognitive function in hypertensives treated with atenolol or propranolol.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900304-1

Atenolol compared with nifedipine: effect on cognitive function and mood in elderly hypertensive patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900304-1

Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900304-1

Effect of antihypertensives on sexual function and quality of life: the TAIM Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900304-1

Comparison of a lifestyle modification program with propranolol use in the management of diastolic hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900304-1

The effects of mild diastolic hypertension on the results of tests of cognitive function in adults 22 to 59 years of age

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900304-1

The effects of stimulant drugs on information processing in elderly adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900304-1

The effects of clonidine and yohimbine on human information processing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900304-1

Impairment of memory function by antihypertensive medication.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900304-1

The effect of methylphenidate on information processing.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900304-1

The California Verbal Learning Test: psychometric characteristics and clinical application

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900304-1

The CES-D Scale: A Self-Report Depression Scale for Research in the General Population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900304-1

An Inventory for Measuring Depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900304-1

Confidence intervals for reporting results of clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900304-1

Confidence intervals assess both clinical significance and statistical significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900304-1

The effects of antihypertensive therapy on the quality of life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900304-1

Quality of life and antihypertensive therapy in men. A comparison of captopril with enalapril. The Quality-of-Life Hypertension Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900304-1

Antihypertensive therapy--efficacy and quality of life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900304-1

Quality of life with three antihypertensive treatments. Cilazapril, atenolol, nifedipine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900304-1

Quality of life among hypertensive patients with a diuretic background who are taking atenolol and enalapril.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900304-1

A randomized controlled trial of the effects of three antihypertensive agents on blood pressure control and quality of life in older women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900304-1

Blood pressure and cognitive performance. The Framingham Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900304-1

Treatment of hypertension in the elderly: II. Cognitive and behavioral function. Results of a Department of Veterans Affairs Cooperative Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900304-1

10.1016/S0002-9343(00)00304-1

7 January 2021

Identifiers

DOI

1 reference

8 October 2017

1 reference